Galafold 123 MG (as migalastat HCl 150 MG) Oral Capsule
- RxCUI
- 2054263
- RxNorm name
- Galafold 123 MG (as migalastat HCl 150 MG) Oral Capsule
- Display name
- Galafold 123 MG (as migalastat HCl 150 MG) Oral Capsule
- Full name
- Galafold 123 MG (as migalastat HCl 150 MG) Oral Capsule
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:01
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Galafold | MIGALASTAT HYDROCHLORIDE | Amicus Therapeutics US, LLC | 66dbd928-0f1c-48b1-a832-54e4abd9f1db | 2025-08-28 | Adverse reactions | 2054263 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 66dbd928-0f1c-48b1-a832-54e4abd9f1db | Galafold 123 MG Oral Capsule [PSN] · migalastat 123 MG Oral Capsule [Galafold] [SBD] · Galafold 123 MG (as migalastat HCl 150 MG) Oral Capsule [SY] · Galafold 123 MG Oral Capsule [SY] | 4 | 18 | These highlights do not include all the information needed to use GALAFOLD safely and effectively. See full prescribing information for GALAFOLD. GALAFOLD ® (migalastat) capsules, for oral use Initial U.S. Approval: 2018 | 20250828 |